These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12383985)

  • 21. Randomized controlled trial of zinc and vitamin A as co-adjuvants for the treatment of pulmonary tuberculosis.
    Lawson L; Thacher TD; Yassin MA; Onuoha NA; Usman A; Emenyonu NE; Shenkin A; Davies PD; Cuevas LE
    Trop Med Int Health; 2010 Dec; 15(12):1481-90. PubMed ID: 20958890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis.
    Batbold U; Butov DO; Kutsyna GA; Damdinpurev N; Grinishina EA; Mijiddorj O; Kovolev ME; Baasanjav K; Butova TS; Sandagdorj M; Batbold O; Tseveendorj A; Chunt E; Zaitzeva SI; Stepanenko HL; Makeeva NI; Mospan IV; Pylypchuk VS; Rowe JL; Nyasulu P; Jirathitikal V; Bain AI; Tarakanovskaya MG; Bourinbaiar AS
    Immunotherapy; 2017 Jan; 9(1):13-24. PubMed ID: 27868466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis.
    Johnson JL; Okwera A; Vjecha MJ; Byekwaso F; Nakibali J; Nyole S; Milberg J; Aisu T; Whalen CC; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):446-53. PubMed ID: 9441100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary tuberculosis in HIV-infected patients presenting with normal chest radiograph and negative sputum smear.
    Palmieri F; Girardi E; Pellicelli AM; Rianda A; Bordi E; Rizzi EB; Petrosillo N; Ippolito G
    Infection; 2002 Apr; 30(2):68-74. PubMed ID: 12018472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-year follow-up of patients with pulmonary tuberculosis in Guinea-Bissau, West Africa.
    Winqvist N; Nauclér A; Gomes V; Djamanca I; Koivula T; Jensen H; Dias F; Biberfeld G; Källenius G; Norberg R
    Int J Tuberc Lung Dis; 2000 Sep; 4(9):845-52. PubMed ID: 10985653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.
    Heemskerk AD; Bang ND; Mai NT; Chau TT; Phu NH; Loc PP; Chau NV; Hien TT; Dung NH; Lan NT; Lan NH; Lan NN; Phong le T; Vien NN; Hien NQ; Yen NT; Ha DT; Day JN; Caws M; Merson L; Thinh TT; Wolbers M; Thwaites GE; Farrar JJ
    N Engl J Med; 2016 Jan; 374(2):124-34. PubMed ID: 26760084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective evaluation of antituberculosis therapy in patients with human immunodeficiency virus infection.
    Jones BE; Otaya M; Antoniskis D; Sian S; Wang F; Mercado A; Davidson PT; Barnes PF
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1499-502. PubMed ID: 7952606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis.
    Elliott AM; Luzze H; Quigley MA; Nakiyingi JS; Kyaligonza S; Namujju PB; Ducar C; Ellner JJ; Whitworth JA; Mugerwa R; Johnson JL; Okwera A
    J Infect Dis; 2004 Sep; 190(5):869-78. PubMed ID: 15295690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial.
    Penn-Nicholson A; Tameris M; Smit E; Day TA; Musvosvi M; Jayashankar L; Vergara J; Mabwe S; Bilek N; Geldenhuys H; Luabeya AK; Ellis R; Ginsberg AM; Hanekom WA; Reed SG; Coler RN; Scriba TJ; Hatherill M;
    Lancet Respir Med; 2018 Apr; 6(4):287-298. PubMed ID: 29595510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire.
    Ackah AN; Coulibaly D; Digbeu H; Diallo K; Vetter KM; Coulibaly IM; Greenberg AE; De Cock KM
    Lancet; 1995 Mar; 345(8950):607-10. PubMed ID: 7898177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A refined symptom-based approach to diagnose pulmonary tuberculosis in children.
    Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N
    Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial.
    Hawken MP; Meme HK; Elliott LC; Chakaya JM; Morris JS; Githui WA; Juma ES; Odhiambo JA; Thiong'o LN; Kimari JN; Ngugi EN; Bwayo JJ; Gilks CF; Plummer FA; Porter JD; Nunn PP; McAdam KP
    AIDS; 1997 Jun; 11(7):875-82. PubMed ID: 9189212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis. The Makerere University-Case Western Reserve University Research Collaboration.
    Whalen C; Okwera A; Johnson J; Vjecha M; Hom D; Wallis R; Huebner R; Mugerwa R; Ellner J
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1977-81. PubMed ID: 8665064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of vitamin D
    Sudfeld CR; Mugusi F; Aboud S; Nagu TJ; Wang M; Fawzi WW
    Trials; 2017 Feb; 18(1):66. PubMed ID: 28183335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial.
    Fitzgerald DW; Desvarieux M; Severe P; Joseph P; Johnson WD; Pape JW
    Lancet; 2000 Oct; 356(9240):1470-4. PubMed ID: 11081529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis.
    Huang CY; Hsieh WY
    Hum Vaccin Immunother; 2017 Sep; 13(9):1960-1971. PubMed ID: 28604170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial.
    Nunn AJ; Mwaba P; Chintu C; Mwinga A; Darbyshire JH; Zumla A;
    BMJ; 2008 Jul; 337():a257. PubMed ID: 18617486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months.
    Perriëns JH; St Louis ME; Mukadi YB; Brown C; Prignot J; Pouthier F; Portaels F; Willame JC; Mandala JK; Kaboto M
    N Engl J Med; 1995 Mar; 332(12):779-84. PubMed ID: 7862181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antitubercular drug treatment failure and HIV infection in Abidjan (Ivory Coast)].
    Daix T; Domoua K; Coulibaly G; Kissi H; Beugre-Sy L; Yapi A
    Bull Soc Pathol Exot; 2003 Mar; 96(1):39-40. PubMed ID: 12784592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial.
    Samandari T; Agizew TB; Nyirenda S; Tedla Z; Sibanda T; Shang N; Mosimaneotsile B; Motsamai OI; Bozeman L; Davis MK; Talbot EA; Moeti TL; Moffat HJ; Kilmarx PH; Castro KG; Wells CD
    Lancet; 2011 May; 377(9777):1588-98. PubMed ID: 21492926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.